Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. (Record no. 16988551)

MARC details
000 -LEADER
fixed length control field 02292 a2200709 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515064132.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200705s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1526-632X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1212/01.wnl.0000259521.14704.a8
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Balcer, L J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070511
245 00 - TITLE STATEMENT
Title Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Neurology
Date of publication, distribution, etc. Apr 2007
300 ## - PHYSICAL DESCRIPTION
Extent 1299-304 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Contrast Sensitivity
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunosuppressive Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Sclerosis, Relapsing-Remitting
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Natalizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neurologic Examination
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Placebos
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Predictive Value of Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vision Tests
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vision, Low
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Visual Acuity
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Visual Pathways
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Galetta, S L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Calabresi, P A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Confavreux, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giovannoni, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Havrdova, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hutchinson, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kappos, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lublin, F D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miller, D H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Connor, P W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Phillips, J T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Polman, C H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Radue, E-W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rudick, R A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stuart, W H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wajgt, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weinstock-Guttman, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wynn, D R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lynn, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Panzara, M A
773 0# - HOST ITEM ENTRY
Title Neurology
Related parts vol. 68
-- no. 16
-- p. 1299-304
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1212/01.wnl.0000259521.14704.a8">https://doi.org/10.1212/01.wnl.0000259521.14704.a8</a>
Public note Available from publisher's website

No items available.